Together, this study expands the current understanding of how tumor-secreted factors, specifically TGF-β1, impact neutrophil response and skew neutrophils to support tumor progression, which can inform the design of effective therapeutic strategies against cancer progression and metastasis. The gene discussed is TGFB1; the disease is neoplasm.